TERT and neoplasm: Conversely, the inhibition of miR500A decreased tumour invasiveness but, interestingly, only in the tumour cells that express TERT, suggesting the existence of other players in the in vivo invasive capacity of SAOS 2 cells and demonstrating that TERT increases tumour invasiveness through miR500A. The inhibition of miR500A in another telomerase‐positive cell line, HeLa 1211, resulted in a similar outcome, confirming that the same mechanism operates in different tumour histotypes.